Aquestive Therapeutics, Inc. - COM (AQST)

Historical Portfolio Holders from Q3 2018 to Q2 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q2	20.1 K	$52.4 K	+$9.11 K			$2.60	2
2024 Q1	41.5 M	$177 M	+$88.1 M	1.83 M	1.94 M	$4.26	96
2023 Q4	23.8 M	$48.1 M	+$1.93 M	85.2 K	260 K	$2.02	57
2023 Q3	13.1 M	$20 M	+$5.8 M	21.1 K	123 K	$1.53	45
2023 Q2	19.1 M	$31.4 M	+$6.9 M	1.32 K	60.1 K	$1.65	53
2023 Q1	14.9 M	$17 M	+$180 K	342	20.1 K	$1.14	35
2022 Q4	14.9 M	$13.5 M	-$889 K	722	45.3 K	$0.90	35
2022 Q3	15.8 M	$18.5 M	-$675 K		0	$1.17	38
2022 Q2	16.7 M	$10.6 M	-$1.17 M	0	33 K	$0.64	38
2022 Q1	15.5 M	$40.5 M	-$1.65 M	223 K	198 K	$2.61	47
2021 Q4	15.9 M	$62 M	+$1.65 M	947 K	631 K	$3.89	49
2021 Q3	14.6 M	$63.8 M	-$1.97 M	650 K	614 K	$4.36	40
2021 Q2	15 M	$59.7 M	-$7.4 M	388 K	333 K	$3.97	52
2021 Q1	15.4 M	$80 M	-$14.5 M	1.09 M	447 K	$5.20	58
2020 Q4	18.2 M	$97.3 M	-$4.07 M	880 K	77 K	$5.35	61
2020 Q3	19.9 M	$96.5 M	+$6.81 M	1.14 M	124 K	$4.85	57
2020 Q2	18.5 M	$90 M	+$16.4 M	535 K	612 K	$4.86	56
2020 Q1	15.9 M	$34.9 M	-$11.2 M			$2.19	40
2019 Q4	17.4 M	$101 M	+$20.5 M			$5.82	51
2019 Q3	13.6 M	$43.1 M	-$3.62 M			$3.18	31
2019 Q2	14.5 M	$61 M	-$1.01 M			$4.20	36
2019 Q1	14.4 M	$99.6 M	+$457 K			$6.91	46
2018 Q4	14.4 M	$90.5 M	-$233 M			$6.30	36
2018 Q3	16.1 M	$282 M	+$282 M			$17.51	43